We joined forces with InSphero to advance the field of 3D organotypic modeling in drug discovery. Leveraging InSphero’s expertise in developing scalable and reproducible organotypic models and our deep learning image analysis solutions, our mutual project aims to enhance the translational value of compound screening.
